Related Experiment Video
Updated: Jun 13, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Mdm2 facilitates the association of p53 with the proteasome
Roman Kulikov1, Justine Letienne, Manjit Kaur
1Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, P.O. Box 3640, 76021 Karlsruhe, Germany.
Abstract:
The ubiquitin ligase Mdm2 targets the p53 tumor suppressor protein for proteasomal degradation. Mutating phosphorylation sites in the central domain of Mdm2 prevents p53 degradation, although it is still ubiquitylated, indicating that Mdm2 has a post-ubiquitylation function for p53 degradation. We show that Mdm2 associates with several subunits of the 19S proteasome regulatory particle in a ubiquitylation-independent manner. Mdm2 furthermore promotes the formation of a ternary complex of itself, p53, and the proteasome. Replacing phosphorylation sites within the central domain with alanines reduced the formation of the ternary complex. The C-terminus of Mdm2 was sufficient for interaction with the proteasome despite an additional proteasome binding site in the Mdm2 N-terminus. In addition to binding to the proteasome, the C-terminus of Mdm2 bound to the central domain, possibly competing with, and therefore blocking, Mdm2/proteasome interaction. We propose that Mdm2 facilitates, or at least enhances, the association of p53 with the proteasome and that phosphorylation of the central domain of Mdm2 regulates this process.
Insights
The Mdm2 protein targets p53 for degradation. Phosphorylation sites in Mdm2 regulate its interaction with the proteasome, controlling p53 degradation post-ubiquitylation.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- The ubiquitin ligase Mdm2 is a key regulator of the p53 tumor suppressor.
- Mdm2 targets p53 for degradation via the proteasome.
- Mutations in Mdm2's phosphorylation sites suggest a post-ubiquitylation role in p53 degradation.
Purpose of the Study:
- To investigate the role of Mdm2 in p53 proteasomal degradation.
- To elucidate the mechanism by which Mdm2 interacts with the proteasome.
- To determine how Mdm2 phosphorylation sites affect p53 degradation and proteasome association.
Main Methods:
- Site-directed mutagenesis of Mdm2 phosphorylation sites.
- Co-immunoprecipitation assays to study protein interactions.
- Analysis of Mdm2-p53-proteasome ternary complex formation.
Main Results:
- Mdm2 binds to proteasome subunits independently of ubiquitylation.
- Mdm2 promotes the formation of a ternary complex with p53 and the proteasome.
- Mutating Mdm2 phosphorylation sites impairs ternary complex formation and p53 degradation.
- Mdm2's C-terminus mediates proteasome interaction, while its central domain can inhibit this interaction.
Conclusions:
- Mdm2 facilitates p53 association with the proteasome.
- Phosphorylation of Mdm2's central domain regulates this interaction and subsequent p53 degradation.
- Mdm2 possesses a post-ubiquitylation function critical for p53 degradation.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage Can Stall the Cell Cycle

